Highly stable, ligand-clustered "patchy" micelle nanocarriers for systemic tumor targeting.
暂无分享,去创建一个
Paula T Hammond | P. Hammond | Z. Poon | J. A. Lee | Zhiyong Poon | R. Prevost | Jung Ah Lee | Shenwen Huang | Richard J Prevost | Shenwen Huang
[1] Malcolm Rowland,et al. Clearance concepts in pharmacokinetics , 1973, Journal of Pharmacokinetics and Biopharmaceutics.
[2] Tae-You Kim,et al. Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies , 2004, Clinical Cancer Research.
[3] P. Low,et al. Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[4] Robert J. Lee,et al. A Folate Receptor–Targeted Lipid Nanoparticle Formulation for a Lipophilic Paclitaxel Prodrug , 2004, Pharmaceutical Research.
[5] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[6] T. V. van Berkel,et al. Lysine-based Cluster Mannosides That Inhibit Ligand Binding to the Human Mannose Receptor at Nanomolar Concentration* , 1996, The Journal of Biological Chemistry.
[7] P. Hammond,et al. Comb-Dendritic Block Copolymers as Tree-Shaped Macromolecular Amphiphiles for Nanoparticle Self-Assembly , 2006 .
[8] J. Richie,et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. Duncan. The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.
[10] A. Gabizon. Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] R. Bellamkonda,et al. Decreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of glioma , 2007 .
[12] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[13] W. Hunter,et al. Development of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel , 1999 .
[14] Chun Xing Li,et al. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. , 1998, Cancer research.
[15] H. Ueno,et al. A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation , 2007, British Journal of Cancer.
[16] Thommey P. Thomas,et al. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. , 2005, Cancer research.
[17] D. Maysinger,et al. Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles , 2003, Science.
[18] L G Griffith,et al. Cell adhesion and motility depend on nanoscale RGD clustering. , 2000, Journal of cell science.
[19] P. Cullis,et al. Drug Delivery Systems: Entering the Mainstream , 2004, Science.
[20] H. S. Oh,et al. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[21] A. Lavasanifar,et al. The effect of block copolymer structure on the internalization of polymeric micelles by human breast cancer cells. , 2005, Colloids and surfaces. B, Biointerfaces.
[22] Felix Kratz,et al. Polymer therapeutics: concepts and applications. , 2006, Angewandte Chemie.
[23] Francis C Szoka,et al. Designing dendrimers for biological applications , 2005, Nature Biotechnology.
[24] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[25] J. Reddy,et al. Targeting therapeutic and imaging agents to folate receptor positive tumors. , 2005, Current pharmaceutical biotechnology.
[26] R. Donehower,et al. Drug therapy : paclitaxel (Taxol) , 1995 .
[27] D. Maysinger,et al. Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approach. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[28] S. Balasubramanian,et al. Taxol-lipid interactions: taxol-dependent effects on the physical properties of model membranes. , 1994, Biochemistry.
[29] Robert Langer,et al. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers , 2008, Proceedings of the National Academy of Sciences.
[30] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[31] R. J. Lee,et al. Targeted drug delivery via the folate receptor. , 2000, Advanced drug delivery reviews.
[32] Yokoyama Masayuki,et al. Block copolymer micelles as vehicles for drug delivery , 1993 .
[33] Sung-Bae Kim,et al. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer , 2008, Breast Cancer Research and Treatment.
[34] Wolfgang A. Weber,et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.
[35] P. Wils,et al. Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors , 2002, Gene Therapy.
[36] P. Low,et al. Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells. , 1999, Blood.
[37] Sangeeta N Bhatia,et al. Ligand-clustered "patchy" nanoparticles for modulated cellular uptake and in vivo tumor targeting. , 2010, Angewandte Chemie.
[38] Teruo Okano,et al. Polymeric micelles as new drug carriers , 1996 .
[39] T. Honda,et al. Design of Folate-Linked Liposomal Doxorubicin to its Antitumor Effect in Mice , 2008, Clinical Cancer Research.
[40] U. Nielsen,et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.
[41] M. Ratnam,et al. The folate receptor: What does it promise in tissue-targeted therapeutics? , 2007, Cancer and Metastasis Reviews.
[42] Tae Gwan Park,et al. Folate receptor targeted biodegradable polymeric doxorubicin micelles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[43] Samuel Zalipsky,et al. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[44] P. Low,et al. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. , 2005, Analytical biochemistry.
[45] B R Goldspiel,et al. Paclitaxel (Taxol) , 1994, Pharmacotherapy.
[46] P. Low,et al. Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug Delivery , 2004, Molecular Pharmacology.
[47] Philip S Low,et al. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential. , 2004, Advanced drug delivery reviews.